3//SEC Filing
Takeda Pharmaceuticals U.S.A., Inc. 3
Accession 0000899243-18-008945
CIK 0001679082other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 8:50 PM ET
Size
18.8 KB
Accession
0000899243-18-008945
Insider Transaction Report
Form 3
MILLENNIUM PHARMACEUTICALS INC
10% Owner
Holdings
- 7,420,625
Common Stock
Takeda Pharmaceuticals U.S.A., Inc.
10% Owner
Holdings
- 7,420,625
Common Stock
Footnotes (2)
- [F1]On March 19, 2018, Takeda Pharmaceuticals International AG ("TPIZ") sold 7,420,625 shares of common stock of Myovant Sciences Ltd. to Millennium Pharmaceuticals, Inc. ("Millennium"). As of the date of this filing: Millennium is owned by Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA"); 41.05% of the outstanding common stock of TPUSA is owned by TPIZ and 58.95% of the outstanding common stock of TPUSA is owned by Takeda Pharmaceuticals Company Limited ("TPC"); 86.831% of the outstanding shares of TPIZ are owned by Takeda Pharma A/S (Denmark) ("TPAS") and 13.1680% of the outstanding shares of TPIZ are owned by Takeda Europe Holdings BV (Netherlands) ("TEHBV"); TPAS is owned by Takeda A/S (Denmark) ("TAS"); 76.09% of the outstanding shares of TAS are owned by TPC and 23.91% of the outstanding shares of TAS are owned by TEHBV.
- [F2](Continued from footnote 1) TEHBV is wholly-owned by TPC. TPIZ, TPC, TPAS, TEHBV and TAS previously reported this transaction on a Form 4 filed March 21, 2018. Each of the Reporting Persons (other than Millennium) disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein.
Issuer
Myovant Sciences Ltd.
CIK 0001679082
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001716229
Filing Metadata
- Form type
- 3
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 8:50 PM ET
- Size
- 18.8 KB